CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...